Daniel A. Burkholder

Risk of Hepatocellular Carcinoma in Patients With Indeterminate (LI-RADS 3) Liver Observations

Ashwini Arvind, Sagar Joshi, Timothy A. Zaki et al. · Clinical Gastroenterology and Hepatology · 2021 · 36 citations · Full text

Medicine, Oncology, Radiology +14

Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotype

Vincent Chen, Daniel A. Burkholder, Isabel J. Moran et al. · JHEP Reports · 2022 · 28 citations · Full text

Medicine, Internal Medicine, Molecular Genetics +10

Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications

Daniel A. Burkholder, Isabel J. Moran, Jacob V. DiBattista et al. · Digestive Diseases and Sciences · 2021 · 22 citations

Medicine, Clinical Sciences, Internal Medicine +16

Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort

Jacob V. DiBattista, Daniel A. Burkholder, Anna S. Lok et al. · Digestive Diseases and Sciences · 2022 · 18 citations

Medicine, Internal Medicine, Radiology +14

Clinical Outcomes of Patients With Suspicious (LI-RADS 4) Liver Observations

Kristeen Onyirioha, Sagar Joshi, Daniel A. Burkholder et al. · Clinical Gastroenterology and Hepatology · 2022 · 16 citations

Medicine, Radiology, Diagnostic Imaging +14